Moderna secures agreement for mRNA facility in Kenya

2023-04-24T07:13:00

Moderna has finalised an agreement with the Government of the Republic of Kenya to build an mRNA-specific facility in Kenya which will eventually be capable of producing up to 500 million doses of vaccine per year.

How to read this article

Thank you for visiting Regulatory Rapporteur, you have now used up your content views.

To continuing reading you can register for free, join TOPRA, or if you are a member login now.

1. REGISTER FOR FREE

Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

Create your own library to save your favourite content.

Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.

3. JOIN TOPRA

TOPRA membership

Become a TOPRA member and join our global regulatory affairs community

Great savings on our events and training.
Be part of our dynamic international community.
Contribute to the profession.
Grow your skills and knowledge.
Take your career to the next level.

Become a member